Sasanquasaponin from Camellia oleifera Abel. induces cell cycle arrest and apoptosis in human breast cancer MCF-7 cells

Fitoterapia

Volumn 84, Issue 1, 2013, Pages 123-129

  Chen, Linyan ^a   Chen, Jing ^b   Xu, Hanhong ^a  

^a SOUTH CHINA AGRICULTURAL UNIVERSITY   (China)

^b INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

Author keywords

Apoptosis; Cell cycle; Cyclin D1; E2F1; p53; Sasanquasaponin

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLIN D1; PROTEIN P21; PROTEIN P53; SASANQUASAPONIN; TRANSCRIPTION FACTOR E2F1; TRITERPENOID; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; BREAST CANCER; CAMELLIA OLEIFERA; CELL ACTIVATION; CELL CYCLE ARREST; CELL CYCLE PROGRESSION; CELL DEATH; CELL GROWTH; CELL PROLIFERATION; CELL STIMULATION; CELL STRAIN MCF 7; CELL VIABILITY; CONCENTRATION RESPONSE; DOWN REGULATION; G1 PHASE CELL CYCLE CHECKPOINT; G2 PHASE CELL CYCLE CHECKPOINT; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; PROTEIN EXPRESSION; S PHASE CELL CYCLE CHECKPOINT; SIGNAL TRANSDUCTION; TEA;

APOPTOSIS; CAMELLIA; CELL CYCLE CHECKPOINTS; CYCLIN D1; CYCLIN-DEPENDENT KINASE INHIBITOR P21; FEMALE; GENE EXPRESSION REGULATION; HUMANS; MCF-7 CELLS; MOLECULAR STRUCTURE; SAPONINS;

EID: 84873371044     PISSN: 0367326X     EISSN: 18736971     Source Type: Journal    
DOI: 10.1016/j.fitote.2012.11.009     Document Type: Article

References (37)

1. E. Marshall Epidemiology. Search for a killer: focus shifts from fat to hormones Science 259 1993 618 621
2. N.M. Perera, and G.P. Gui Multi-ethnic differences in breast cancer: current concepts and future directions Int J Cancer 106 2003 463 467
3. ACS Cancer Statistics. A presentation from the American Cancer Society (Ed.). American Cancer Society Inc. 2004.
4. S. Germano, and L. O'Driscoll Breast cancer: understanding sensitivity and resistance to chemotherapy and targeted therapies to aid in personalised medicine Curr Cancer Drug Targets 9 2009 398 418
5. C. O'Brien, G. Cavet, A. Pandita, X. Hu, L. Haydu, and S. Mohan Functional genomics identifies ABCC3 as amediator of taxane resistance in HER2-amplified breast cancer Cancer Res 68 2008 5380 5389
6. X. Pivot, L. Asmar, A.U. Buzdar, V. Valero, and G. Hortobagyi A unified definition of clinical anthracycline resistance breast cancer Br J Cancer 82 2000 529 534
7. P.L. Bedard, E. de Azambuja, and F. Cardoso Beyond trastuzumab: overcoming resistance to targeted HER-2 therapy in breast cancer Curr Cancer Drug Targets 9 2009 148 162
8. L.C. Dorssers, S. Van der Flier, A. Brinkman, T. van Agthoven, J. Veldscholte, and E.M. Berns Tamoxifen resistance in breast cancer: elucidating mechanisms Drugs 61 2001 1721 1733
9. J.F. Forbes The control of breast cancer: the role of tamoxifen Semin Oncol 24 Suppl. 1 1997 5
10. W.J. Huang, C.L. Wu, C.W. Lin, L.L. Chi, P.Y. Chen, and C.J. Chiu Marchantin A, a cyclic bis (bibenzyl ether), isolated from the liverwort Marchantia emarginata subsp. tosana induces apoptosis in human MCF-7 breast cancer cells Cancer Lett 291 2010 108 119
11. N. Kim Butein sensitizes human leukemia cells to apoptosis induced by tumor necrosis factor-related apoptosis inducing ligand (TRAIL) Arch Pharm Res 31 2008 1179 1186
12. M. Xian, K. Ito, T. Nakazato, T. Shimizu, C.K. Chen, and K. Yamato Zerumbone, a bioactive sesquiterpene, induces G2/M cell cycle arrest and apoptosis in leukemia cells via a Fas- and mitochondria-mediated pathway Cancer Sci 98 2007 118 126
13. X.F. Zhang, Y.Y. Han, G.H. Bao, T.J. Ling, L. Zhang, and L.P. Gao A new saponin from tea seed pomace (Camellia oleifera Abel.) and its protective effect on PC12 cells Molecules 17 2012 11721 11728
14. Y.F. Chen, C.H. Yang, M.S. Chang, Y.P. Ciou, and Y.C. Huang Foam properties and detergent abilities of the saponins from Camellia oleifera Int J Mol Sci 11 2010 4417 4425
15. J. Yan, Z.L. Wu, Y.L. Zhao, and C.S. Jiang Separation of tea saponin by two-stage foam fractionation Sep Purif Technol 80 2011 300 305
16. H.P. Chen, M. He, Q.R. Huang, D. Liu, and M. Huang Sasanquasaponin protects rat cardiomyocytes against oxidative stress induced by anoxia-reoxygenation injury Eur J Pharmacol 575 2007 21 27
17. A.S. Attele, J.A. Wu, and C.S. Yuan Ginseng pharmacology: multiple constituents and multiple actions Biochem Pharmacol 58 1999 1685 1693
18. C.X. Liu, and P.G. Xiao Recent advances on ginseng research in China J Ethnopharmacol 36 1992 27 38
19. Y.M. Sagesaka, T. Uemura, Y. Suzuki, T. Sugiura, M. Yoshida, and K. Yamaguchi Antimicrobial and anti-inflammatory actions of tea-leaf saponin Yakugaku Zasshi 116 1996 238 243
20. L.Y. Ma, L. Li, Y. Jiang, L.Y. Shi, B.M. Feng, and Y.Q. Wang Youchasaponin induces apoptosis of human leukemia Jurkat cells in vitro and its possible mechanism Tumor 31 2011 1072 1076
21. L.Y. Ma, L. Li, Y. Jiang, L.Y. Shi, B.M. Feng, and Y.Q. Wang Study on Youchasaponin-induced apoptosis of HepG2 cells through the endoplasmic reticulum stress Chin Pharmacol Bull 27 2011 1523 1527
22. Q.R. Huang, L.J. Shao, M. He, H.P. Chen, D. Liu, and Y.M. Luo Inhibitory effects of sasanquasaponin on over-expression of ICAM-1 and on enhancement of capillary permeability induced by burns in rats Burns 31 2005 637 642
23. E.R. McDonald, and W.S. El-Deiry Cell cycle control as a basis for cancer drug development Int J Oncol 16 2000 871 886
24. T. Owa, H. Yoshino, K. Yoshimatsu, and T. Nagasu Cell cycle regulation in the G1 phase: a promising target for the development of new chemotherapeutic anticancer agents Curr Med Chem 8 2001 1487 1503
25. D.J. Newman, G.M. Cragg, and K.M. Snader The influence of natural products upon drug discovery Nat Prod Rep 17 2000 215 234
26. L.A. Carey Directed therapy of subtypes of triple-negative breast cancer Oncologist 15 Suppl. 5 2010 49 56
27. E. Evrone, C.B. Umbricht, D. Korz, V. Raman, D.M. Loeb, and B. Niranjan Loss of cyclin D2 expression in the majority of breast cancer is associated with promoter hypermethylation Cancer Res 61 2001 2782 2787
28. J.W. Harper, S.J. Elledge, K. Keyomarsi, G. Dynlacht, L.H. Tsai, and P. Zhang Inhibition of cyclin-dependent kinases by p21 Mol Biol Cell 6 1995 387 400
29. V. Baldin, J. Lukas, M.J. Marcote, M. Pagano, and G. Draetta Cyclin D1 is a nuclear protein required for cell cycle progression in G1 Genes Dev 7 1993 812 821
30. Q. Yu, Y. Geng, and P. Sicinski Specific protection against breast cancers by cyclin D1 ablation Nature 411 2001 1017 1021
31. G.M. Wulf, A. Ryo, G.G. Wulf, S.W. Lee, T. Niu, and K.P. Lu Pin1 is overexpressed in breast cancer and cooperates with Ras signaling in increasing the transcriptional activity of c-Jun towards cyclin D1 EMBO J 20 2001 3459 3472
32. S.Y. Sun, P. Yue, G.S. Wu, W.S. El-Deiry, B. Shroot, and W.K. Hong Implication of p53 in growth arrest and apoptosis induced by the synthetic retinoid CD437 in human lung cancer cells Cancer Res 59 1999 2829 2833
33. M.S. Weng, Y.S. Ho, and J.K. Lin Chrysin induces G1 phase cell cycle arrest in C6 glioma cells through inducing p21Waf1/Cip1 expression: involvement of p38 mitogen-activated protein kinase Biochem Pharmacol 69 2005 1815 1827
34. T. Stiewe, and B.M. Putzer Role of the p53-homologue p73 in E2F1-induced apoptosis Nat Genet 26 2000 464 469
35. M. Irwin, M.C. Marin, A.C. Phillips, R.S. Seelan, D.I. Smith, and W. Liu Role for the p53 homologue p73 in E2F-1-induced apoptosis Nature 407 2000 645 648
36. N.A. Lissy, P.K. Davis, M. Irwin, W.G. Kaelin, and S.F. Dowdy A common E2F-1 and p73 pathway mediates cell death induced by TCR activation Nature 407 2000 642 645
37. L.L. Seville, N. Shah, A.D. Westwell, and W.C. Chan Modulation of pRB/E2F functions in the regulation of cell cycle and in cancer Curr Cancer Drug Targets 5 2005 159 170